GSK plc
GLAXF
$19.36
$0.0050.03%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.30% | 4.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.30% | 4.83% | |||
| Cost of Revenue | 7.25% | 16.46% | |||
| Gross Profit | -3.39% | 0.71% | |||
| SG&A Expenses | -31.37% | 62.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 161.83% | 6.18% | |||
| Total Operating Expenses | -4.60% | 33.65% | |||
| Operating Income | 47.10% | -68.94% | |||
| Income Before Tax | 765.73% | -95.58% | |||
| Income Tax Expenses | 6,201.65% | -100.54% | |||
| Earnings from Continuing Operations | 658.54% | -94.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 30.39% | 3.14% | |||
| Net Income | 802.46% | -105.10% | |||
| EBIT | 47.10% | -68.94% | |||
| EBITDA | -7.00% | -41.52% | |||
| EPS Basic | 802.16% | -105.10% | |||
| Normalized Basic EPS | 104.06% | -80.75% | |||
| EPS Diluted | 796.22% | -105.15% | |||
| Normalized Diluted EPS | 103.82% | -80.83% | |||
| Average Basic Shares Outstanding | 0.02% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.10% | 0.46% | |||
| Dividend Per Share | 4.97% | 3.17% | |||
| Payout Ratio | 1.14% | -19.98% | |||
